Markus Germann
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 1
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Marco CECCHINI (7 shared papers)George Niklaus Thalmann (6 shared papers)Antoinette Wetterwald (3 shared papers)Cyrill A. Rentsch (6 shared papers)Natalia Guzmán‐Ramírez (2 shared papers)Gabri van der Pluijm (2 shared papers)Jordane Malaterre (6 shared papers)Robert George Ramsay (6 shared papers)
- Journals
- Stem Cell Research (2 papers)The Prostate (2 papers)Science Translational Medicine (1 paper)Nature Communications (1 paper)Annals of Surgical Oncology (1 paper)
- Partner nations
- SwitzerlandAustraliaNetherlands
In The Last Decade
Markus Germann
18 papers receiving 750 citations
Peers
Comparison fields: 5 of 55
- Oncology 292
- Immunology 126
- Pulmonary and Respiratory Medicine 197
- Cancer Research 46
- Molecular Biology 205
Countries citing papers authored by Markus Germann
This map shows the geographic impact of Markus Germann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Germann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Germann more than expected).
Fields of papers citing papers by Markus Germann
This network shows the impact of papers produced by Markus Germann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Germann. The network helps show where Markus Germann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Germann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 138 | |
| 2 | 2012 | 99 | |
| 3 | 2009 | 78 | |
| 4 | 2013 | 70 | |
| 5 | 2023 | 70 | |
| 6 | 2015 | 42 | |
| 7 | 2005 | 36 | |
| 8 | 2014 | 36 | |
| 9 | 2012 | 32 | |
| 10 | 2010 | 30 | |
| 11 | 2011 | 24 | |
| 12 | 2012 | 23 | |
| 13 | 2022 | 20 | |
| 14 | 2015 | 19 | |
| 15 | 2014 | 16 | |
| 16 | 2015 | 14 | |
| 17 | Characterization and Clinical Relevance of ALDH bright Populations in Prostate Cancer | 2013 | 6 |
| 18 | 2025 | 5 | |
| 19 | 2025 | 0 |
About Markus Germann
Markus Germann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 19 papers that have together received 758 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Cancer Cells and Metastasis (3 papers), Genetic factors in colorectal cancer (2 papers), Immune cells in cancer (1 paper), Cancer-related Molecular Pathways (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Oncology (292 citations), Immunology (126 citations), Pulmonary and Respiratory Medicine (197 citations), Cancer Research (46 citations) and Molecular Biology (205 citations). Markus Germann has collaborated with scholars based in Switzerland, Australia and Netherlands. Frequent co-authors include Marco CECCHINI, George Niklaus Thalmann, Antoinette Wetterwald, Cyrill A. Rentsch, Natalia Guzmán‐Ramírez, Gabri van der Pluijm, Jordane Malaterre, Robert George Ramsay, Sabine Tejpar and Amber D. Bowler. Their work appears in journals such as Stem Cell Research, The Prostate, Science Translational Medicine, Nature Communications and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.